Literature DB >> 29954

Pharmacokinetics of flunitrazepam following single- and multiple-dose oral administration to healthy human subjects.

H G Boxenbaum, H N Posmanter, T Macasieb, K A Geitner, R E Weinfeld, J D Moore, A Darragh, D A O'Kelly, L Weissman, S A Kaplan.   

Abstract

Healthy human subjects received single and multiple oral doses of flunitrazepam. Absorption and disposition were first order and reproducible from administration. The oral doses were virtually completely available to the liver, and elimination from the body occurred entirely via metabolism. Assuming the liver to be the sole eliminating organ, hepatic blood clearance and extraction ratio were approximately 0.235 liter/hr/kg and 0.154, respectively. Steady-state blood volume of distribution averaged 3.76 liters/kg in the single-dose studies. Terminal exponential half-lives from the single- and multiple-dose studies (different subjects) averaged 13.5 and 19.2 hr, respectively; these differences were not due to clearance changes but were entirely attributable to variations in volumes of distribution.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 29954     DOI: 10.1007/BF01060092

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  7 in total

1.  Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects.

Authors:  F B Eatman; W A Colburn; H G Boxenbaum; H N Posmanter; R E Weinfeld; R Ronfeld; L Weissman; J D Moore; M Gibaldi; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

2.  Determination of clonazepam and flunitrazepam in blood and urine by electron-capture GLC.

Authors:  J A De Silva; C V Puglisi; N Munno
Journal:  J Pharm Sci       Date:  1974-04       Impact factor: 3.534

3.  Use of cannulated everted intestinal sac for serial sampling as a drug absorbability (permeability) screen.

Authors:  S A Kaplan; S Cotler
Journal:  J Pharm Sci       Date:  1972-09       Impact factor: 3.534

4.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

Review 5.  Hepatic vascular bed.

Authors:  C V Greenway; R D Stark
Journal:  Physiol Rev       Date:  1971-01       Impact factor: 37.312

6.  Determination of clonazepam and flunitrazepam in blood by electron-capture gas-liquid chromatography.

Authors:  J A de Silva; I Bekersky
Journal:  J Chromatogr       Date:  1974-11-06

7.  Improved holder for intrinsic dissolution rate studies.

Authors:  J Wood; J Syarto; H Letterman
Journal:  J Pharm Sci       Date:  1965-07       Impact factor: 3.534

  7 in total
  13 in total

1.  Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors:  Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

Review 2.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

3.  Comparative pharmacokinetics of benzodiazepines in dog and man.

Authors:  H Boxenbaum
Journal:  J Pharmacokinet Biopharm       Date:  1982-08

4.  The classification of benzodiazepine hypnotics.

Authors:  D M Pierce; R A Franklin
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

5.  Pharmacokinetic and clinical considerations in the choice of a hypnotic.

Authors:  R Amrein; M Eckert; H Haefeli; B Leishman
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

6.  Residual effects of repeated doses of 0.5 and 1 mg flunitrazepam.

Authors:  M Lader; A Melhuish; P Harris
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 7.  Hypnotics. Their place in therapeutics.

Authors:  A N Nicholson
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

8.  A time-dependent volume of distribution term used to describe linear concentration-time profiles.

Authors:  W A Colburn
Journal:  J Pharmacokinet Biopharm       Date:  1983-08

Review 9.  Pharmacological treatment of insomnia.

Authors:  M Maczaj
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

10.  A radioreceptor assay to study the affinity of benzodiazepines and their receptor binding activity in human plasma including their active metabolites.

Authors:  R G Dorow; J Seidler; H H Schneider
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.